Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand.
This report describes age-related alterations of dendritic cells (DC) distribution in nude athymic mice in vivo and reversal of certain age-dependent defects by an in vivo administration of hematopoietic growth factor FLT3 ligand (FLT3L). There are decreased percentages of CD11c(+) DC in the bone marrow and spleen and a reduced expression of MHC class II and CD86 molecules on DC in old nude mice. The decreased levels of CD11c(+) DC were due to the CD8alpha(-) DC subset. The distribution of CD11c(+) CD8alpha(+) DC in the lymphoid tissues was not different in young and old mice. The effect of in vivo administration of FLT3L on the generation and distribution of DC in the lymphoid tissues in young and old nude mice was also evaluated. Although, FLT3L had a higher inductive potential on the expansion of DC from the bone marrow in the elderly mice, the total level of CD11c(+) DC in the young animals was still significantly higher as compared to the old animals. Interestingly, FLT3L induced a pronounced redistribution and accumulation of MHC class II(+) DC in the lymphoid tissues in old mice, markedly increased the accumulation of CD8alpha(-) DC in the bone marrow in both young and old nude mice, and elevated both CD8alpha(-) and CD8alpha(+) DC in the spleen in young mice. However, only the level of CD8alpha(+) DC was up regulated in the spleen in old athymic mice after FLT3L-based therapy. In summary, abnormalities in DC generation and distribution in old athymic mice could be, in part, circumvented by the in vivo administration of FLT3L.
Shurin
Galina V
GV
Department of Pediatrics, University of Pittsburgh Medical Center, 5725 Main Tower Childrens Hospital, 200 Lothrop Street, Pdittsburgh, PA 15213, USA. shurinmr@upmc.edu
Chatta
Gurkamal S
GS
Tourkova
Irina L
IL
Zorina
Tatiana D
TD
Esche
Clemens
C
Shurin
Michael R
MR
D000375:Aging / Q000276:immunology*; D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D051940:B7-2 Antigen; D001853:Bone Marrow / Q000276:immunology; D039521:CD11c Antigen / Q000032:analysis; D016827:CD8 Antigens / Q000032:analysis; D002455:Cell Division / Q000187:drug effects; D003713:Dendritic Cells / Q000166:cytology* / Q000276:immunology; D005434:Flow Cytometry; D000949:Histocompatibility Antigens Class II; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis; D008565:Membrane Proteins / Q000494:pharmacology*; D051379:Mice; D008819:Mice, Nude; D013154:Spleen / Q000276:immunology
D015703:Antigens, CD; D051940:B7-2 Antigen; D039521:CD11c Antigen; D016827:CD8 Antigens; C497965:Cd86 protein, mouse; D000949:Histocompatibility Antigens Class II; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; C084881:flt3 ligand protein